BioPharmX Makes New Appointment
This article was originally published in Scrip
BioPharmX Corporation, a company focusing on dermatology and women's health, has appointed AnnaMarie Daniels executive vice-president of clinical and regulatory affairs. Daniels has led regulatory pathway strategies with the FDA and Global Regulatory Authorities and other programs with Johnson & Johnson and Boston Scientific Neuromodulation. Previously she held various executive, technical and independent consulting level positions in companies including Target Therapeutics, Cervel Neurotech, ReVENT Medical and Merz Pharmaceuticals.